BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 3805797)

  • 1. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
    Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
    Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
    Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paucibacillary multidrug therapy in leprosy. 7 1/2 years experience.
    Kaur S; Sharma VK; Basak P; Kaur I
    Indian J Lepr; 1992; 64(2):153-61. PubMed ID: 1607713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug therapy in hospitalised leprosy cases.
    Tiwari VD; Tutakne MA; Singh G; Dutta RK
    Indian J Lepr; 1988 Jan; 60(1):71-6. PubMed ID: 3204277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
    Kumar B; Kaur S; Kaur I
    Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of leprosy today].
    Bahmer FA; Menzel S
    Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term chemotherapy of paucibacillary leprosy.
    Dhir R; Guha PK; Singh G
    Indian J Lepr; 1986; 58(4):549-54. PubMed ID: 3572096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.